Elevated Lipoprotein(a) in Patients Without Comorbidities: Which Imaging Tests Should be Ordered?
ABC Imagem Cardiovascular · 29.06.2026 · 39 (2)
DOI: 10.36660/abcimg.20260053i ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC Imagem Cardiovascular, erschienen am 29.06.2026. Verfasst von Eduardo Gomes Lima und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
The incorporation of lipoprotein(a) [Lp(a)] into contemporary cardiovascular risk assessment has introduced a practical question that is increasingly common in clinical practice: when faced with an elevated result, how should risk be reclassified and what management should be adopted, given that current guidelines recommend measuring Lp(a) at least once in adulthood and recognize it as a risk-modifying factor., However, the cardiovascular risk estimation proposed by these same guidelines — based on prognostic scores such as Predicting Risk of Cardiovascular Disease [...]
Zitieren
APA
Lima, E. G., Carvalho, L. N. S., Emerich, T. M. S., Amorim, E. F., & Rached, F. H. (2026). Elevated Lipoprotein(a) in Patients Without Comorbidities: Which Imaging Tests Should be Ordered?. ABC Imagem Cardiovascular, 39(2). https://doi.org/10.36660/abcimg.20260053i
Vancouver
Lima EG, Carvalho LNS, Emerich TMS, Amorim EF, Rached FH. Elevated Lipoprotein(a) in Patients Without Comorbidities: Which Imaging Tests Should be Ordered?. ABC Imagem Cardiovascular. 2026;39(2). doi:10.36660/abcimg.20260053i
BibTeX
@article{Lima2026,
author = {Lima, Eduardo Gomes and Carvalho, Leticia Neves Solon and Emerich, Tatiane Mascarenhas Santiago and Amorim, Eduardo Ferreira and Rached, Fabiana Hanna},
title = {Elevated Lipoprotein(a) in Patients Without Comorbidities: Which Imaging Tests Should be Ordered?},
journal = {ABC Imagem Cardiovascular},
year = {2026},
volume = {39},
number = {2},
doi = {10.36660/abcimg.20260053i}
}
EUVIMED